Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00401622 · ClinicalTrials.gov registry record · NA
Clinical Benefits of a Blood Glucose Monitoring System in Patients With Type 2 Diabetes
A NA study, sponsored by LifeScan.
- Completed
- Registry status
- NA
- Development phase
- 320
- Enrollment target
NCT00401622 is a NA study that has completed, run by LifeScan. The registered enrollment target is 320 participants.
The verdict
NCT00401622, a NA study, has completed, sponsored by LifeScan.
- COMPLETED
- Registry status
- NA
- Development phase
- 320 participants
- Enrollment target
Study Summary
Clinical benefits of the OneTouch® Ultra®2 BGMS versus standard BGMS during 52 weeks of use.
Interventions
- BEHAVIORAL Standard care
- BEHAVIORAL OneTouch® Ultra®2 System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 320 participants |
| Start Date | 2006-10-01 |
| Est. Completion | 2009-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00401622
The ClinicalTrials.gov registry entry for NCT00401622 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 320 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is LifeScan, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard care is the first listed.
NCT00401622 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00401622 about?
NCT00401622 is a clinical study titled "Clinical Benefits of a Blood Glucose Monitoring System in Patients With Type 2 Diabetes". Clinical benefits of the OneTouch® Ultra®2 BGMS versus standard BGMS during 52 weeks of use.
What is the current status of trial NCT00401622?
This trial is currently completed. It is a NA study. The enrollment target is 320 participants. The study started on 2006-10-01. Estimated completion is 2009-01-01.
What interventions are being tested in trial NCT00401622?
The interventions under investigation include: Standard care (BEHAVIORAL), OneTouch® Ultra®2 System (BEHAVIORAL).
Who is sponsoring clinical trial NCT00401622?
This trial is sponsored by LifeScan, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.